TELIX PHARMACEUTIC financial statements, including revenue, expenses, and profit

The total revenue of TLX1/N for the last semiannual is 5.41 B MXN, and it's 21.52% higher compared to the previous semiannual. The net income of H2 24 is 261.40 M MXN.